Phio Pharmaceuticals (PHIO) Institutional Ownership → $21,000 in profits in six weeks? (From InvestorPlace) (Ad) Free PHIO Stock Alerts $0.80 -0.04 (-4.78%) (As of 05/8/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Phio Pharmaceuticals (NASDAQ:PHIO)CurrentInstitutional OwnershipPercentage57.31%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$124.09KNumber ofInstitutional Sellers(last 12 months)0 Get PHIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Phio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PHIO Institutional Buying and Selling by Quarter Ad Behind the MarketsBREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> Phio Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2023Anson Funds Management LP22,571$65K0.0%N/A1.505% 8/10/2023Cetera Investment Advisers10,666$31K0.0%N/A0.711% 8/2/2023Bank of Montreal Can10,000$38K0.0%N/A0.667% 8/11/2022Cetera Investment Advisers75,000$53K0.0%-16.7%0.549% 11/16/2021Cetera Investment Advisers30,000$61K0.0%N/A0.222% 11/9/2021BlackRock Inc.35,592$72K0.0%-17.8%0.263% 9/17/2021Virtu Financial LLC27,110$61K0.0%+74.7%0.200% 8/13/2021Vanguard Group Inc.276,561$625K0.0%+125.4%2.043% 8/12/2021Dimensional Fund Advisors LP23,960$54K0.0%-31.2%0.177% 5/19/2021Virtu Financial LLC15,522$42K0.0%N/A0.115% 5/14/2021Dimensional Fund Advisors LP34,808$93K0.0%+38.3%0.257% 5/12/2021Geode Capital Management LLC87,501$234K0.0%+330.6%0.647% 5/10/2021 GSA Capital Partners LLP132,333$355K0.1%+30.5%0.978% 3/26/2021Susquehanna International Group LLP12,058$32K0.0%N/A0.085% 3/8/2021Dimensional Fund Advisors LP25,177$68K0.0%N/A0.178% 2/25/2021Dimensional Fund Advisors LP25,177$68K0.0%N/A0.178% 2/4/2021 GSA Capital Partners LLP101,401$273K0.0%+376.6%1.754% 12/11/2020Virtu Financial LLC35,929$77K0.0%N/A0.622% 11/6/2020 GSA Capital Partners LLP21,278$46K0.0%N/A0.368% 7/16/2020Wedbush Securities Inc.33,374$73K0.0%N/A0.577% 5/15/2020Sabby Management LLC255,194$452K0.2%N/A8.901% 5/12/2020JPMorgan Chase & Co.21,681$38K0.0%N/A0.755% (Data available from 1/1/2016 forward) PHIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PHIO shares? During the previous two years, the following institutional investors and hedge funds held shares of Phio Pharmaceuticals shares: Anson Funds Management LP ($65K), and Bank of Montreal Can ($38K), Cetera Investment Advisers ($31K).Learn more on PHIO's institutional investors. What percentage of Phio Pharmaceuticals stock is owned by institutional investors? 57.31% of Phio Pharmaceuticals stock is owned by institutional investors. Learn more on PHIO's institutional investor holdings. Which institutional investors have been buying Phio Pharmaceuticals stock? The following institutional investors have purchased Phio Pharmaceuticals stock in the last 24 months: Anson Funds Management LP ($22.57K), Cetera Investment Advisers ($10.67K), and Bank of Montreal Can ($10K). How much institutional buying is happening at Phio Pharmaceuticals? Institutional investors have bought a total of 43,237 shares in the last 24 months. This purchase volume represents approximately $124.09K in transactions. Which Phio Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Phio Pharmaceuticals stock in the last 24 months: Cetera Investment Advisers ($15K). How much institutional selling is happening at Phio Pharmaceuticals? Institutional investors have sold a total of 15,000 shares in the last 24 months. This volume of shares sold represents approximately $10.53K in transactions. Related Companies: VRPX Institutional Ownership GOVX Institutional Ownership AGRX Institutional Ownership REVB Institutional Ownership ARAV Institutional Ownership NBY Institutional Ownership BCEL Institutional Ownership RNAZ Institutional Ownership CLVR Institutional Ownership SXTP Institutional Ownership This page (NASDAQ:PHIO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phio Pharmaceuticals Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
